X @Forbes
Forbes·2026-08-26 23:30
The FDA has approved a new medication for pancreatic cancer patients called daraxonrasib, a once-daily pill that blocks RAS proteins and has been shown to double patient survival time when compared to standard chemotherapy treatment.Read more: https://t.co/Em6Pb1TqRi📸: Sarah Silbiger via Getty Images ...